Approval · Notice of Compliance 25509 · 2021
CEFA-LAK: Notice of Compliance 25509
Issued March 23, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25509
- Date
- March 23, 2021
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of drug substance manufacturing site, manufacturing changes
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFA-LAK | 02173263 | Marketed |
Medicinal ingredients
- CEPHAPIRIN SODIUM 200 MG per 10ML